Not approved as Inhalation suspension for nebulization, Conduct CT: CDSCO Panel Tells Glenmark on Pulmonary FDC Dr. Divya Colin2 April 2024 6:00 PM ISTNew Delhi: Noting that the proposed fixed-dose combination (FDC) of Glycopyrrolate plus Formoterol Fumarate Dihydrate plus Budesonide (25mcg+20mcg+500...
CDSCO Drug Alert: 58 Drug Samples Including Alkems's Pyricool 500, Sun Pharma's Zole F Flagged Dr. Divya Colin1 April 2024 6:00 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Standard Control Organisation (CDSCO) has flagged 58 medicine...
Submit Current Safety Data of Indians: CDSCO Panel Tells Glenmark on anti-cancer drug ISB1442 Dr. Divya Colin26 March 2024 6:00 PM ISTNew Delhi: Reviewing the Phase I/II clinical study protocol of the anti-cancer drug ISB1442 presented by the drug major Glenmark, the Subject Expert...
Indian Pharma Market registers 8 percent surge to Rs 17,937 Crore in January 2024: IQVIA Farhat Nasim19 Feb 2024 7:19 PM ISTNew Delhi: In an impressive kickoff to 2024, the Indian pharmaceutical market surged by 8%, reaching a substantial Rs 17,937 crore in January, as per...
CCI approves acquisition of majority shareholding of Glenmark Life Sciences by Nirma Ruchika Sharma21 Dec 2023 2:52 PM ISTNew Delhi: The Competition Commission of India (CCI) has approved acquisition of majority shareholding of the Glenmark Life Sciences Limited by...
Glenmark Gets CDSCO panel nod to market FDC of Bilastine, Dextromethorphan, Phenylephrine Syrup Dr. Divya Colin22 Nov 2023 6:00 PM ISTNew Delhi: Citing that the proposed fixed-dose combination (FDC) of Bilastine 3.3mg/5ml plus Dextromethorphan Hydrobromide 10mg/5ml plus Phenylephrine...
Generate safety and efficacy data: CDSCO Tells Glenmark Over Glimipride, Lobeglitazone FDC Dr. Divya Colin13 Nov 2023 3:30 PM ISTNew Delhi: In response to the proposal presented by the drug major Glenmark Pharmaceuticals to conduct the Phase IV clinical trial of the fixed-dose...
Show lung deposition of triple drug combination in Inhalation Suspension: CDSCO Panel tells Glenmark on Pulmonary FDC Drug Dr. Divya Colin2 Nov 2023 5:37 PM ISTNew Delhi: In line with the proposal presented by the drug major Glenmark Pharmaceuticals for the bioequivalence (BE) and Phase III clinical trial...
Glenmark Pharma bags USFDA nod for generic version of Otezla Tablets Ruchika Sharma18 Oct 2023 3:30 PM ISTMumbai: Glenmark Pharmaceuticals Ltd. has announced that the Company has received final approval from the United States Food & Drug Administration...
Include more Govt sites: CDSCO panel tells Glenmark on asthma drug combination Roshni Dhar9 Oct 2023 3:04 PM ISTCiting that more government sites shall be included in the study with geographical distribution, the Subject Expert Committee (SEC) functional under...
Health Bulletin 07/October/2023 Roshni Dhar7 Oct 2023 4:43 PM ISTHere are the top health stories of the day:Professional Conduct Review - Lessons from case archives: NMC unveils its first publicationThrough a recent...
Submit BE study, Phase III trial protocol: CDSCO panel tells Glenmark on Metformin, Glimepiride, Lobeglitazon FDC Susmita Roy1 Oct 2023 6:00 PM ISTNew Delhi: Citing the proposed fixed-dose combination (FDC) is not approved internationally, the Subject Expert Committee (SEC) functional under the...
